Ikena Oncology Q4 EPS $(0.41) Beats $(0.43) Estimate, Sales $658.00K Miss $3.14M Estimate
Ikena Oncology Q4 EPS $(0.41) Beats $(0.43) Estimate, Sales $658.00K Miss $3.14M Estimate
Ikena Oncology第四季度每股收益美元（0.41美元）超過預期（0.43美元），銷售額爲658.00萬美元，低於314萬美元的預期
Ikena Oncology (NASDAQ:IKNA) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.43) by 4.65 percent. This is a 5.13 percent decrease over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $658.00 thousand which missed the analyst consensus estimate of $3.14 million by 79.04 percent. This is a 87.93 percent decrease over sales of $5.45 million the same period last year.
Ikena Oncology（納斯達克股票代碼：IKNA）公佈的季度虧損爲每股0.41美元，比分析師普遍預期的0.43美元（0.43美元）高出4.65％。這比去年同期每股虧損0.39美元（0.39美元）下降了5.13％。該公司公佈的季度銷售額爲65.8萬美元，比分析師普遍預期的314萬美元低79.04％。這比去年同期的545萬美元銷售額下降了87.93％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。